Candace S Johnson Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2019	Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness.
1/2018	Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).
1/2015	Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP.
2/2014	Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients.
1/2014	Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.
9/2013	Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue.
6/2013	Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.
4/2013	Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.
8/2011	Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate.
3/2011	Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Candace S Johnson Research Topics

Disease

69	Neoplasms (Cancer) 01/2023 - 01/2002
31	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2002
19	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 01/2002
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015 - 07/2002
7	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2011
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 07/2010
7	Neoplasm Metastasis (Metastasis) 09/2017 - 05/2006
4	Vitamin D Deficiency 01/2019 - 02/2009
4	Leukemia 02/2014 - 05/2004
3	Inflammation (Inflammations) 01/2016 - 06/2010
3	Lung Neoplasms (Lung Cancer) 05/2008 - 05/2004
2	7 Hereditary Prostate Cancer 01/2019 - 01/2018
2	Adenocarcinoma 01/2014 - 03/2007
2	Colorectal Neoplasms (Colorectal Cancer) 08/2013 - 02/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 01/2010
2	Lymphoma (Lymphomas) 07/2006 - 05/2004
1	Acute Pain 01/2023
1	Adenocarcinoma of Lung 03/2020
1	Residual Neoplasm 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Granular Cell Tumor 10/2015
1	Carcinogenesis 09/2015
1	Mouth Neoplasms (Oral Cancer) 09/2015
1	Squamous Cell Carcinoma of Head and Neck 09/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2014
1	Carcinoma (Carcinomatosis) 02/2014
1	Chromothripsis 02/2014

Drug/Important Bio-Agent (IBA)

43	Vitamin D FDA LinkGeneric 01/2021 - 01/2002
41	Calcitriol (Calcijex)FDA LinkGeneric 01/2016 - 01/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 01/2002
11	AndrogensIBA 01/2014 - 01/2002
10	Cholecalciferol (Vitamin D3)FDA Link 03/2020 - 01/2006
9	hydroxide ionIBA 01/2019 - 01/2010
7	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2002
7	GlucocorticoidsIBA 10/2011 - 01/2002
6	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2017 - 09/2002
6	Vitamin D3 24-HydroxylaseIBA 01/2016 - 07/2010
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2003
5	Estrogen ReceptorsIBA 01/2021 - 02/2011
5	CalciumIBA 01/2018 - 07/2006
5	EnzymesIBA 01/2016 - 07/2006
5	25-hydroxyvitamin DIBA 01/2015 - 02/2011
5	Carboplatin (JM8)FDA LinkGeneric 07/2010 - 01/2002
4	1,25-dihydroxyvitamin DIBA 01/2019 - 07/2002
4	MicroRNAs (MicroRNA)IBA 04/2015 - 01/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2010 - 01/2002
4	Docetaxel (Taxotere)FDA Link 07/2010 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2014
3	LigandsIBA 01/2016 - 07/2006
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2015 - 08/2002
3	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 07/2010
3	Hormones (Hormone)IBA 01/2014 - 08/2004
3	Gemcitabine FDA Link 08/2010 - 07/2010
3	matrigelIBA 07/2010 - 09/2006
3	Taxoids (Taxanes)IBA 07/2006 - 01/2004
2	protein C activator peptideIBA 01/2018 - 01/2015
2	CarcinogensIBA 09/2015 - 05/2004
2	Cadherins (E-Cadherin)IBA 01/2014 - 02/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 06/2010
2	SteroidsIBA 09/2010 - 07/2010
2	Cytidine DeaminaseIBA 08/2010 - 01/2007
2	MineralsIBA 07/2010 - 07/2006
2	Gefitinib (Iressa)FDA Link 12/2009 - 02/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2006 - 07/2004
2	VA 061 (VA061)IBA 07/2006 - 05/2004
2	allyl isothiocyanateIBA 10/2003 - 05/2003
2	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 10/2003 - 05/2003
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 03/2020
1	MagnesiumIBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	AmberIBA 05/2016
1	N-nitroso-tris-chloroethylureaIBA 10/2015
1	pazopanib FDA Link 10/2015
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 09/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2015
1	ErbB Receptors (EGF Receptor)IBA 09/2015
1	Calcifediol (Calcidiol)FDA Link 01/2015
1	NucleotidesIBA 02/2014
1	Ionotropic Glutamate ReceptorsIBA 02/2014
1	Interleukin-5 (Interleukin 5)IBA 01/2014
1	CytokinesIBA 01/2014
1	QW 1624F2-1IBA 01/2014
1	Differentiation AntigensIBA 01/2014
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2013
1	Cell Adhesion MoleculesIBA 09/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2013
1	von Willebrand FactorIBA 09/2013
1	A-factor (Streptomyces)IBA 07/2013
1	Oxygen (Dioxygen)IBA 06/2013
1	Angiogenesis InhibitorsIBA 06/2013
1	LuciferasesIBA 04/2013
1	Casein Kinase II (Casein Kinase 2)IBA 04/2013

Therapy/Procedure

18	Therapeutics 01/2021 - 01/2002
3	Prostatectomy (Retropubic Prostatectomy) 02/2014 - 05/2009
3	Drug Therapy (Chemotherapy) 07/2010 - 02/2009
2	Castration 01/2014 - 01/2010
1	Cystectomy 01/2019
1	Segmental Mastectomy (Lumpectomy) 10/2016
1	Chemoprevention 09/2015